Rheumatoid Arthritis

In Rheumatoid Arthritis (RA), the most common chronic inflammatory joint disease, autoantibodies attack the joints and cause joint destruction. Below are COVID news and research updates that specifically relate to RA.

COVID-19 Outcomes in Those with Rheumatic Diseases

A study published recently in the International Journal of Rheumatic Diseases looked to “assess the characteristics of inflammatory rheumatic disease (IRD) patients in Kuwait diagnosed with COVID-19 and the factors linked with hospitalization, complications, and mortality.”

Read More »

Weighing the Pros and Cons of Pausing Methotrexate for COVID shots

A recently published study in the Annals of the Rheumatic Diseases analyzed the pros and cons of pausing methotrexate usage. The group that continued their regular medication regimen demonstrated a 55% antibody response from the COVID vaccines whereas the group that paused methotrexate demonstrated an 80% antibody response.

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.